Memed Diagnostics Ltd
CAGE Code: 3503A
NCAGE Code: 3503A
Status: Active
Type: Manufacturer
Summary
Memed Diagnostics Ltd is an Active Manufacturer with the Cage Code 3503A.
Address
5 Nachum Het
Tirat Carmel
3912000
Israel
Points of Contact
No Points of Contact...
Related Information
No Related Information...
Frequently Asked Questions (FAQ) for CAGE 3503A
- What is CAGE Code 3503A?
- 3503A is the unique identifier used by NATO Organizations to reference the physical entity known as Memed Diagnostics Ltd located at 5 Nachum Het, Tirat Carmel, 3912000, Israel.
- Who is CAGE Code 3503A?
- 3503A refers to Memed Diagnostics Ltd located at 5 Nachum Het, Tirat Carmel, 3912000, Israel.
- Where is CAGE Code 3503A Located?
- CAGE Code 3503A is located in Tirat Carmel, Israel.
Contracting History for CAGE 3503A Most Recent 25 Records
- 75A50123C00041
- Memed Diagnostics- The R&D Effort To Demonstrate Clinical Utility Of Memed Bv, Rapid Host-Based Diagnostic (Hbd) For Distinguishing Bacterial Vs Viral Infection
- 22 Sep 2023
- Memed Diagnostics- The R&D Effort To Demonstrate Clinical Utility Of Memed Bv, Rapid Host-Based Diagnostic (Hbd) For Distinguishing Bacterial Vs Viral Infection
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $727,799.32
- Department Of Health And Human Services (Hhs)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 24 Jun 2019
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,231,820.92
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 25 Jan 2019
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,231,820.92
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein Ivd Assay To Poc Device For Rapid Differentiation Of Viral Vs Bacterial Infections
- 26 Oct 2021
- Transition Clinically Approved Host-Protein Ivd Assay To Poc Device For Rapid Differentiation Of Viral Vs Bacterial Infections
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,248,538.40
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 2 Dec 2019
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,368,062.92
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 3 Mar 2020
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,373,294.17
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein Ivd Assay To Poc Device For Rapid Differentiation Of Viral Vs Bacterial Infections.
- 30 Nov 2021
- Transition Clinically Approved Host-Protein Ivd Assay To Poc Device For Rapid Differentiation Of Viral Vs Bacterial Infections.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,248,538.40
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 2 Sep 2020
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,373,294.17
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 30 Oct 2019
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $10,368,062.92
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care (Poc) Device For Rapid Differentiation Of Viral Vs. Bacterial Infections
- 26 Jun 2018
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care (Poc) Device For Rapid Differentiation Of Viral Vs. Bacterial Infections
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $9,555,742.86
- Department Of Defense (Dod)
- HDTRA117C0011
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- 24 Jul 2018
- Transition Clinically Approved Host-Protein In Vitro Diagnostic (Ivd) To Point-Of-Care(Poc)Device For Rapid Differentiation Of Viral Vs. Bacterial Infection.
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $9,555,742.86
- Department Of Defense (Dod)